BrightSpring Health Services, Inc. (NASDAQ:BTSG) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC reduced its holdings in BrightSpring Health Services, Inc. (NASDAQ:BTSG) by 21.0% during the third quarter, Holdings Channel reports. The firm owned 65,060 shares of the company’s stock after selling 17,305 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in BrightSpring Health Services were worth $955,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in BTSG. Bank of New York Mellon Corp grew its position in BrightSpring Health Services by 16.1% in the second quarter. Bank of New York Mellon Corp now owns 156,911 shares of the company’s stock worth $1,783,000 after buying an additional 21,760 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank acquired a new position in shares of BrightSpring Health Services in the 2nd quarter worth $126,000. nVerses Capital LLC acquired a new stake in shares of BrightSpring Health Services during the second quarter worth $55,000. Rhumbline Advisers lifted its holdings in shares of BrightSpring Health Services by 20.4% during the second quarter. Rhumbline Advisers now owns 73,643 shares of the company’s stock valued at $837,000 after purchasing an additional 12,479 shares during the last quarter. Finally, TD Asset Management Inc purchased a new stake in shares of BrightSpring Health Services during the second quarter valued at $2,308,000.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the company. Guggenheim lifted their price target on BrightSpring Health Services from $15.00 to $18.00 and gave the stock a “buy” rating in a research note on Tuesday, October 1st. KeyCorp began coverage on shares of BrightSpring Health Services in a report on Friday, October 11th. They set a “sector weight” rating on the stock. Morgan Stanley upped their price target on shares of BrightSpring Health Services from $19.00 to $20.00 and gave the company an “overweight” rating in a research report on Tuesday. UBS Group lifted their price objective on shares of BrightSpring Health Services from $16.00 to $20.00 and gave the stock a “buy” rating in a research report on Wednesday, October 30th. Finally, CJS Securities assumed coverage on BrightSpring Health Services in a report on Thursday, December 12th. They issued an “outperform” rating and a $27.00 target price for the company. One investment analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. According to MarketBeat.com, BrightSpring Health Services has an average rating of “Moderate Buy” and a consensus target price of $18.65.

BrightSpring Health Services Trading Down 7.2 %

NASDAQ BTSG opened at $17.13 on Thursday. The company has a current ratio of 1.35, a quick ratio of 0.97 and a debt-to-equity ratio of 1.63. BrightSpring Health Services, Inc. has a 1-year low of $7.85 and a 1-year high of $20.25. The firm’s fifty day simple moving average is $17.64 and its 200-day simple moving average is $14.19. The company has a market capitalization of $2.98 billion and a PE ratio of -65.88.

BrightSpring Health Services (NASDAQ:BTSG) last issued its earnings results on Friday, November 1st. The company reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.07). BrightSpring Health Services had a negative net margin of 0.38% and a positive return on equity of 4.16%. The firm had revenue of $2.91 billion during the quarter, compared to analysts’ expectations of $2.72 billion. The business’s quarterly revenue was up 28.8% compared to the same quarter last year. As a group, sell-side analysts anticipate that BrightSpring Health Services, Inc. will post 0.59 earnings per share for the current fiscal year.

BrightSpring Health Services Profile

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.